Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Breast

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.breast.2017.09.007PMID 29020660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High Resolution Melting Analysis is Very Useful to Identify Breast Cancer Type 1 Susceptibility Protein (BRCA1) c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA

  2017cited by this paper
• Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool

  2016cited by this paper
• Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy

  2016cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Comparison of predicted and actual consequences of missense mutations

  2015cited by this paper
• Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Genetics of breast cancer: a topic in evolution.

  2015cited by this paper
• Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?

  2014cited by this paper
• Structure-Function of the Tumor Suppressor BRCA1

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer

  2010cited by this paper
• Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

  2010cited by this paper
• PARP inhibition in BRCA-mutated breast and ovarian cancers.

  2010cited by this paper
• Prognosis of BRCA-associated breast cancer: a summary of evidence

  2009cited by this paper
• Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis

  2008cited by this paper
• BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.

  2008cited by this paper
• Susceptibility genes in breast cancer: more is less?

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

  2006cited by this paper
• Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

  2006cited by this paper
• BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.

  2005cited by this paper
• Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening

  2005cited by this paper
• BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy

  2003cited by this paper
• Structural insights into BRCA2 function.

  2003cited by this paper
• BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

  2001cited by this paper
• Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer

  2001cited by this paper
• The Breast Cancer Information Core: Database design, structure, and scope

  2000cited by this paper
• BRCA1 and BRCA2 mutations in central and southern Italian patients

  2000cited by this paper
• Roles of BRCA1 and its interacting proteins

  2000cited by this paper
• BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Genetic predisposition to breast cancer

  1984cited by this paper

• BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning.

  2022cites this paper
• Germline Alterations in Patients With IBD-associated Colorectal Cancer.

  2021cites this paper
• BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic

  2020cites this paper
• A new founder BRCA1 haplotype identified in the Puglia region is associated with a specific age-related cancer onset in three unrelated families

  2020cites this paper
• BRCA testing delay during the COVID-19 pandemic: How to act?

  2020cites this paper
• Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome

  2020influential citation
• Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer

  2020cites this paper
• Novel bioinformatics quality control metric for next-generation sequencing experiments in the clinical context

  2019cites this paper